246 related articles for article (PubMed ID: 95475)
1. [Immunological problems in oncology (author's transl)].
Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
[TBL] [Abstract][Full Text] [Related]
2. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
3. Tumor immunology.
Shehadeh IH
J Med Liban; 1972; 25(3):199-203. PubMed ID: 5086706
[No Abstract] [Full Text] [Related]
4. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
Pasternak G
Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
[No Abstract] [Full Text] [Related]
5. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
6. The role of immunological enhancement for the growth of autochthonous tumors.
Hellström I; Hellström KE
Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
[No Abstract] [Full Text] [Related]
7. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
8. Manipulation of host resistance in cancer therapy.
Baldwin RW
Springer Semin Immunopathol; 1982; 5(2):113-25. PubMed ID: 6755781
[No Abstract] [Full Text] [Related]
9. [Immunodepressive action of the tumor].
Belokhvostov AS
Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712
[No Abstract] [Full Text] [Related]
10. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
11. [Current problems in immunology].
Ambrosius H
Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395
[No Abstract] [Full Text] [Related]
12. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Peggs KS; Quezada SA; Korman AJ; Allison JP
Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
[TBL] [Abstract][Full Text] [Related]
13. [Immunological processes and their morphological manifestations in the development of tumors].
Ageev AK
Arkh Patol; 1974; 36(6):72-80. PubMed ID: 4137423
[No Abstract] [Full Text] [Related]
14. [Tumour immunology (author's transl)].
Sellin D
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():341-9. PubMed ID: 88727
[TBL] [Abstract][Full Text] [Related]
15. [Immunological interrelationships of the body and the tumor].
Govallo VI
Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
[No Abstract] [Full Text] [Related]
16. [Does an immune reactivity to human laryngeal cancer exist?].
Cortesina G; Cavallo GP; Sartoris A; Beatrice F; Morra B; Bussi M; Poggio E
G Batteriol Virol Immunol; 1979; 72(1-6):169-90. PubMed ID: 399929
[TBL] [Abstract][Full Text] [Related]
17. [Host immune response against cancer (author's transl)].
Hashimoto Y
Tanpakushitsu Kakusan Koso; 1978 May; 23(6):615-24. PubMed ID: 358289
[No Abstract] [Full Text] [Related]
18. [NK cells--their role and importance in antitumor resistance].
Mircheva Zh
Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
[No Abstract] [Full Text] [Related]
19. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
Pizza G; De Vinci C
J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
[No Abstract] [Full Text] [Related]
20. Tumor immunology--three decades in review.
Brodt P
Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
